Xperi Inc ownership update: Manulife Investment Management (US) LLC reports beneficial ownership of 2,470,417 shares of Common Stock, representing 5.26% of the class. Manulife Investment Management Limited holds 8,571 shares (0.02%). The filing cites 46,969,801 shares outstanding as of February 16, 2026.
The Schedule 13G/A was filed on behalf of Manulife Financial Corporation and its indirect subsidiaries and includes a certification about the foreign regulatory scheme and a joint filing agreement exhibit.
Positive
None.
Negative
None.
Insights
Manulife's US arm holds a visible 5.26% stake in Xperi.
Manulife Investment Management (US) LLC reports 2,470,417 shares (5.26%) of Xperi common stock, using the issuer's disclosed figure of 46,969,801 shares outstanding as of February 16, 2026. The filing is a routine beneficial ownership disclosure under Schedule 13G/A.
Holder influence depends on voting arrangements and any aggregation of related accounts; the filing lists sole voting and dispositive power for MIM (US). Subsequent filings would show changes to this position.
Filing is procedural with required certifications and joint-filing exhibit.
The amendment includes a certification that MIML's foreign regulatory scheme is substantially comparable and attaches a Joint Filing Agreement as Exhibit A. Signatures are provided by authorized officers and an agent under a prior power of attorney.
This Schedule 13G/A follows passive/qualified investor reporting conventions; governance impact depends on future disclosures or voting coordination among affiliates.
Key Figures
MIM (US) beneficial ownership:2,470,417 sharesMIM (US) percent of class:5.26%MIML beneficial ownership:8,571 shares+3 more
6 metrics
MIM (US) beneficial ownership2,470,417 sharesBeneficial ownership reported by MIM (US)
MIM (US) percent of class5.26%Percent of 46,969,801 shares outstanding as of Feb 16, 2026
MIML beneficial ownership8,571 sharesBeneficial ownership reported by MIML
MIML percent of class0.02%Percent of 46,969,801 shares outstanding as of Feb 16, 2026
Shares outstanding referenced46,969,801 sharesOutstanding shares as of Feb 16, 2026 (issuer's Form 10-K)
Filing signature dates05/06/2026; 05/07/2026Dates of signatures on the Schedule 13G/A amendment
Key Terms
Schedule 13G/A, beneficial ownership, sole dispositive power, joint filing agreement
4 terms
Schedule 13G/Aregulatory
"This filing is made on behalf of Manulife Financial Corporation"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
beneficial ownershipfinancial
"Amount beneficially owned: MIM (US) has beneficial ownership of 2,470,417 shares"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
sole dispositive powerregulatory
"Sole Dispositive Power 2,470,417.00"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
joint filing agreementregulatory
"EXHIBIT A - JOINT FILING AGREEMENT"
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 3)
Xperi Inc
(Name of Issuer)
Common Stock
(Title of Class of Securities)
98423J101
(CUSIP Number)
03/31/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
98423J101
1
Names of Reporting Persons
Manulife Financial Corporation
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
CANADA (FEDERAL LEVEL)
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
0.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0 %
12
Type of Reporting Person (See Instructions)
HC
SCHEDULE 13G
CUSIP Number(s):
98423J101
1
Names of Reporting Persons
Manulife Investment Management Limited
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
CANADA (FEDERAL LEVEL)
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
8,571.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
8,571.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
8,571.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0.02 %
12
Type of Reporting Person (See Instructions)
FI
SCHEDULE 13G
CUSIP Number(s):
98423J101
1
Names of Reporting Persons
Manulife Investment Management (US) LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
2,470,417.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
2,470,417.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
2,470,417.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.26 %
12
Type of Reporting Person (See Instructions)
IA
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Xperi Inc
(b)
Address of issuer's principal executive offices:
2190 Gold Street San Jose, CA, 95002 United States
Item 2.
(a)
Name of person filing:
This filing is made on behalf of Manulife Financial Corporation ("MFC") and MFC's indirect, wholly-owned subsidiaries, Manulife Investment Management (US) LLC ("MIM (US)") and Manulife Investment Management Limited ("MIML")
(b)
Address or principal business office or, if none, residence:
The principal business offices of MFC and MIML are located at 200 Bloor Street East, Toronto, Ontario, Canada, M4W 1E5.
The principal business office of MIM (US) is located at 197 Clarendon Street, Boston, Massachusetts 02116.
(c)
Citizenship:
MFC and MIML are organized and exist under the laws of Canada.
MIM (US) is organized and exists under the laws of the State of Delaware.
(d)
Title of class of securities:
Common Stock
(e)
CUSIP No.:
98423J101
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
FI
Item 4.
Ownership
(a)
Amount beneficially owned:
MIM (US) has beneficial ownership of 2,470,417 shares of Common Stock and MIML has beneficial ownership of 8,571 shares of Common Stock. Through its parent-subsidiary relationship to MIM (US) and MIML, MFC may be deemed to have beneficial ownership of these same shares.
(b)
Percent of class:
Of the 46,969,801 shares of Common Stock outstanding as of February 16, 2026, according to the Form 10-K filed by the issuer with the Securities and Exchange Commission on February 26, 2026, MIM (US) held 5.26% and MIML held 0.02%.
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
Incorporated by reference to Item 5 of the cover page pertaining to each reporting person.
(ii) Shared power to vote or to direct the vote:
Incorporated by reference to Item 6 of the cover page pertaining to each reporting person.
(iii) Sole power to dispose or to direct the disposition of:
Incorporated by reference to Item 7 of the cover page pertaining to each reporting person.
(iv) Shared power to dispose or to direct the disposition of:
Incorporated by reference to Item 8 of the cover page pertaining to each reporting person.
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
See Items 3 and 4 above.
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the foreign regulatory scheme applicable to MIML is substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institution(s). I also undertake to furnish to the Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Manulife Financial Corporation
Signature:
/s/ Graham Miller
Name/Title:
Graham Miller / Agent*
Date:
05/06/2026
Manulife Investment Management Limited
Signature:
/s/ Christopher Walker
Name/Title:
Christopher Walker / Chief Compliance Officer
Date:
05/07/2026
Manulife Investment Management (US) LLC
Signature:
/s/ Paul Donahue
Name/Title:
Paul Donahue / Chief Compliance Officer
Date:
05/06/2026
Comments accompanying signature: *Signed pursuant to a Power of Attorney dated January 17, 2018 included as Exhibit A to Schedule 13F-NT filed with the Securities and Exchange Commission by Manulife Financial Corporation on January 29, 2018.
The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative other than an executive officer or general partner of the filing person, evidence of the representative's authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.
NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See ss.240.13d-7 for other parties for whom copies are to be sent.
Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001)
Manulife Investment Management (US) LLC reports beneficial ownership of 2,470,417 shares, representing 5.26% of Xperi's common stock based on 46,969,801 shares outstanding as of February 16, 2026 according to the filing.
How many shares does Manulife Investment Management Limited hold in Xperi (XPER)?
Manulife Investment Management Limited holds 8,571 shares of Xperi common stock, equal to 0.02% of the class, as reported in the Schedule 13G/A amendment filed on behalf of Manulife Financial Corporation and its subsidiaries.
What outstanding share count does the filing reference for Xperi (XPER)?
The filing cites 46,969,801 shares outstanding of Xperi common stock as of February 16, 2026, referencing the issuer's Form 10-K filed on February 26, 2026 for that outstanding share figure.
Who filed the Schedule 13G/A for Xperi (XPER) on behalf of Manulife?
The Schedule 13G/A was filed on behalf of Manulife Financial Corporation and its indirect subsidiaries Manulife Investment Management (US) LLC and Manulife Investment Management Limited, with signatures from named compliance officers and an authorized agent.
Does the filing include any governance or regulatory certifications for Manulife?
Yes. The amendment contains a certification that the foreign regulatory scheme applicable to MIML is "substantially comparable" to U.S. equivalents and offers to furnish information equivalent to a Schedule 13D upon request.
